Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 5470457, 8 pages
http://dx.doi.org/10.1155/2016/5470457
Review Article

The Role of Mitochondrial Functional Proteins in ROS Production in Ischemic Heart Diseases

1Department of Cardiology, Chengdu Military General Hospital, Chengdu 610083, China
2Department of Cardiology, Third Military Medical University, Chongqing 400042, China
3Department of Ultrasonography, Chengdu Military General Hospital, Chengdu 610083, China

Received 23 December 2015; Revised 27 January 2016; Accepted 28 January 2016

Academic Editor: Sergio Di Meo

Copyright © 2016 Haifeng Pei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., “Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association,” Circulation, vol. 125, no. 1, pp. 188–197, 2012. View at Publisher · View at Google Scholar
  2. H. He, N. Li, Z. Zhao, F. Han, X. Wang, and Y. Zeng, “Ischemic postconditioning improves the expression of cellular membrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction,” Biomedical Reports, vol. 3, pp. 668–674, 2015. View at Publisher · View at Google Scholar
  3. W. H. Townley-Tilson, X. Pi, and L. Xie, “The role of oxygen sensors, hydroxylases, and hif in cardiac function and disease,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 676893, 10 pages, 2015. View at Publisher · View at Google Scholar
  4. Z. W. Zhang, X. C. Xu, T. Liu, and S. Yuan, “Mitochondrion-permeable antioxidants to treat ROS-burst-mediated acute diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6859523, 10 pages, 2016. View at Publisher · View at Google Scholar
  5. E. Murphy and C. Steenbergen, “Preconditioning: the mitochondrial connection,” Annual Review of Physiology, vol. 69, pp. 51–67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Zorov, C. R. Filburn, L.-O. Klotz, J. L. Zweier, and S. J. Sollott, “Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes,” The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1001–1014, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Knowlton, L. Chen, and Z. A. Malik, “Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies,” Journal of Cardiovascular Pharmacology, vol. 63, no. 3, pp. 196–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. F. J. Giordano, “Oxygen, oxidative stress, hypoxia, and heart failure,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Maack, E. R. Dabew, M. Hohl, H.-J. Schäfers, and M. Böhm, “Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning,” Circulation Research, vol. 105, no. 8, pp. 811–817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. F. G. Akar, M. A. Aon, G. F. Tomaselli, and B. O'Rourke, “The mitochondrial origin of postischemic arrhythmias,” The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3527–3535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Schwarz, N. Siddiqi, S. Singh, C. J. Neil, D. K. Dawson, and M. P. Frenneaux, “The breathing heart—mitochondrial respiratory chain dysfunction in cardiac disease,” International Journal of Cardiology, vol. 171, no. 2, pp. 134–143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ide, H. Tsutsui, S. Kinugawa et al., “Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium,” Circulation Research, vol. 85, no. 4, pp. 357–363, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Murphy and C. Steenbergen, “Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury,” Physiological Reviews, vol. 88, no. 2, pp. 581–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Scheubel, M. Tostlebe, A. Simm et al., “Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression,” Journal of the American College of Cardiology, vol. 40, no. 12, pp. 2174–2181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Jarreta, J. Orús, A. Barrientos et al., “Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy,” Cardiovascular Research, vol. 45, no. 4, pp. 860–865, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Arbustini, M. Diegoli, R. Fasani et al., “Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy,” American Journal of Pathology, vol. 153, no. 5, pp. 1501–1510, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. Murphy, “How mitochondria produce reactive oxygen species,” The Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. D. Brand, “The sites and topology of mitochondrial superoxide production,” Experimental Gerontology, vol. 45, no. 7-8, pp. 466–472, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky, “Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion,” American Journal of Physiology—Cell Physiology, vol. 292, no. 1, pp. C137–C147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Chen, C. L. Hoppel, and E. J. Lesnefsky, “Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria,” The Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 1, pp. 200–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Yankovskaya, R. Horsefield, S. Törnroth et al., “Architecture of succinate dehydrogenase and reactive oxygen species generation,” Science, vol. 299, no. 5607, pp. 700–704, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. T. M. Iverson, E. Maklashinas, and G. Cecchinis, “Structural basis for malfunction in complex II,” The Journal of Biological Chemistry, vol. 287, no. 42, pp. 35430–35438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Aldakkak, D. F. Stowe, Q. Chen, E. J. Lesnefsky, and A. K. S. Camara, “Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release,” Cardiovascular Research, vol. 77, no. 2, pp. 406–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Shiva, M. N. Sack, J. J. Greer et al., “Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer,” The Journal of Experimental Medicine, vol. 204, no. 9, pp. 2089–2102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Nadtochiy, L. S. Burwell, and P. S. Brookes, “Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 812–825, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Sam, D. L. Kerstetter, D. R. Pimental et al., “Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium,” Journal of Cardiac Failure, vol. 11, no. 6, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Tarry-Adkins, H. L. Blackmore, M. S. Martin-Gronert et al., “Coenzyme Q10 prevents accelerated cardiac aging in a rat model of poor maternal nutrition and accelerated postnatal growth,” Molecular Metabolism, vol. 2, no. 4, pp. 480–490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Bentinger, K. Brismar, and G. Dallner, “The antioxidant role of coenzyme Q,” Mitochondrion, vol. 7, supplement, pp. S41–S50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Schmelzer, M. Kitano, K. Hosoe, and F. Döring, “Ubiquinol affects the expression of genes involved in PPARα signalling and lipid metabolism without changes in methylation of CpG promoter islands in the liver of mice,” Journal of Clinical Biochemistry and Nutrition, vol. 50, no. 2, pp. 119–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. J. Ochoa, J. L. Quiles, J. R. Huertas, and J. Mataix, “Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 60, no. 8, pp. 970–975, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Molyneux, C. M. Florkowski, P. M. George et al., “Coenzyme Q10: an independent predictor of mortality in chronic heart failure,” Journal of the American College of Cardiology, vol. 52, no. 18, pp. 1435–1441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Mortensen, F. Rosenfeldt, A. Kumar et al., “The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial,” JACC: Heart Failure, vol. 2, no. 6, pp. 641–649, 2014. View at Publisher · View at Google Scholar
  33. M. Bienengraeber, C. Ozcan, and A. Terzic, “Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 7, pp. 861–865, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. McLeod, A. Aziz, R. F. Hoyt Jr., J. P. McCoy Jr., and M. N. Sack, “Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia,” The Journal of Biological Chemistry, vol. 280, no. 39, pp. 33470–33476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Nadtochiy, A. J. Tompkins, and P. S. Brookes, “Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection,” The Biochemical Journal, vol. 395, no. 3, pp. 611–618, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. N. Sack, “Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance,” Cardiovascular Research, vol. 72, no. 2, pp. 210–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Ozcan, M. Palmeri, T. L. Horvath, K. S. Russell, and R. R. Russell III, “Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 304, no. 9, pp. H1192–H1200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Krauss, C.-Y. Zhang, and B. B. Lowell, “The mitochondrial uncoupling-protein homologues,” Nature Reviews Molecular Cell Biology, vol. 6, no. 3, pp. 248–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. S. Echtay, E. Winkler, and M. Klingenberg, “Coenzyme Q is an obligatory cofactor for uncoupling protein function,” Nature, vol. 408, no. 6812, pp. 609–613, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Hoerter, M.-D. Gonzalez-Barroso, E. Couplan et al., “Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage,” Circulation, vol. 110, no. 5, pp. 528–533, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, “Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes,” Circulation Research, vol. 93, no. 3, pp. 192–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. J. Youle and A. M. van der Bliek, “Mitochondrial fission, fusion, and stress,” Science, vol. 337, no. 6098, pp. 1062–1065, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Liesa, M. Palacín, and A. Zorzano, “Mitochondrial dynamics in mammalian health and disease,” Physiological Reviews, vol. 89, no. 3, pp. 799–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Koshiba, S. A. Detmer, J. T. Kaiser, H. Chen, J. M. McCaffery, and D. C. Chan, “Structural basis of mitochondrial tethering by mitofusin complexes,” Science, vol. 305, no. 5685, pp. 858–862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Cipolat, O. Martins de Brito, B. Dal Zilio, and L. Scorrano, “OPA1 requires mitofusin 1 to promote mitochondrial fusion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 45, pp. 15927–15932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Smirnova, L. Griparic, D.-L. Shurland, and A. M. van der Bliek, “Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells,” Molecular Biology of the Cell, vol. 12, no. 8, pp. 2245–2256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Yoon, E. W. Krueger, B. J. Oswald, and M. A. McNiven, “The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1,” Molecular and Cellular Biology, vol. 23, no. 15, pp. 5409–5420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. P. H. Reddy, “Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction,” Journal of Alzheimer's Disease, vol. 40, no. 2, pp. 245–256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. W. W. Sharp, Y. H. Fang, M. Han et al., “Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission,” The FASEB Journal, vol. 28, no. 1, pp. 316–326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Marín-García, A. T. Akhmedov, and G. W. Moe, “Mitochondria in heart failure: the emerging role of mitochondrial dynamics,” Heart Failure Reviews, vol. 18, no. 4, pp. 439–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Chen, Q. Gong, J. P. Stice, and A. A. Knowlton, “Mitochondrial OPA1, apoptosis, and heart failure,” Cardiovascular Research, vol. 84, no. 1, pp. 91–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. S.-B. Ong, S. Subrayan, S. Y. Lim, D. M. Yellon, S. M. Davidson, and D. J. Hausenloy, “Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury,” Circulation, vol. 121, no. 18, pp. 2012–2022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. K. N. Papanicolaou, R. J. Khairallah, G. A. Ngoh et al., “Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes,” Molecular and Cellular Biology, vol. 31, no. 6, pp. 1309–1328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Chen, T. Liu, A. Tran et al., “OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability,” Journal of the American Heart Association, vol. 1, Article ID e003012, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Varanita, M. E. Soriano, V. Romanello et al., “The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage,” Cell Metabolism, vol. 21, no. 6, pp. 834–844, 2015. View at Publisher · View at Google Scholar
  56. M. Sumida, K. Doi, E. Ogasawara et al., “Regulation of mitochondrial dynamics by dynamin-related protein-1 in acute cardiorenal syndrome,” Journal of the American Society of Nephrology, vol. 26, no. 10, pp. 2378–2387, 2015. View at Publisher · View at Google Scholar
  57. A. Chacinska, C. M. Koehler, D. Milenkovic, T. Lithgow, and N. Pfanner, “Importing mitochondrial proteins: machineries and mechanisms,” Cell, vol. 138, no. 4, pp. 628–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. O. Schmidt, N. Pfanner, and C. Meisinger, “Mitochondrial protein import: from proteomics to functional mechanisms,” Nature Reviews Molecular Cell Biology, vol. 11, no. 9, pp. 655–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. J. C. Young, N. J. Hoogenraad, and F. U. Hartl, “Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70,” Cell, vol. 112, no. 1, pp. 41–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Boengler, P. Gres, A. Cabestrero et al., “Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning,” Journal of Molecular and Cellular Cardiology, vol. 41, no. 3, pp. 426–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Wright, K. Terada, M. Yan, I. Sergeev, and M. Mori, “Oxidative stress inhibits the mitochondrial import of preproteins and leads to their degradation,” Experimental Cell Research, vol. 263, no. 1, pp. 107–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Li, M. Qi, C. Li et al., “Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy,” Cell Research, vol. 24, no. 8, pp. 977–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. Yang, W. Sun, and K. Hu, “Molecular mechanism underlying adenosine receptor-mediated mitochondrial targeting of protein kinase C,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1823, no. 4, pp. 950–958, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. J. Hausenloy and D. M. Yellon, “The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 4, pp. 339–341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. C. P. Baines, “The molecular composition of the mitochondrial permeability transition pore,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 6, pp. 850–857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Zhu, M. J. Rebecchi, P. S. A. Glass, P. R. Brink, and L. Liu, “Cardioprotection of the aged rat heart by GSK-3β inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 300, no. 3, pp. H922–H930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. E. N. Dedkova, L. K. Seidlmayer, and L. A. Blatter, “Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure,” Journal of Molecular and Cellular Cardiology, vol. 59, pp. 41–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. P. J. Oliveira, R. Seiça, P. M. Coxito et al., “Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats,” FEBS Letters, vol. 554, no. 3, pp. 511–514, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. D. J. Hausenloy, M. R. Duchen, and D. M. Yellon, “Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury,” Cardiovascular Research, vol. 60, no. 3, pp. 617–625, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Saotome, H. Katoh, Y. Yaguchi et al., “Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 4, pp. H1125–H1132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. M. J. Berridge, P. Lipp, and M. D. Bootman, “The versatility and universality of calcium signalling,” Nature Reviews Molecular Cell Biology, vol. 1, no. 1, pp. 11–21, 2000. View at Google Scholar · View at Scopus
  72. A. B. Aurora, A. I. Mahmoud, X. Luo et al., “MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1222–1232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Liu, E. Takimoto, V. L. Dimaano et al., “Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure,” Circulation Research, vol. 115, no. 1, pp. 44–54, 2014. View at Publisher · View at Google Scholar
  74. P. S. Brookes, Y. Yoon, J. L. Robotham, M. W. Anders, and S.-S. Sheu, “Calcium, ATP, and ROS: a mitochondrial love-hate triangle,” American Journal of Physiology—Cell Physiology, vol. 287, no. 4, pp. C817–C833, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Aldakkak, A. K. S. Camara, J. S. Heisner, M. Yang, and D. F. Stowe, “Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts,” Pharmacological Research, vol. 64, no. 4, pp. 381–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. M. L. Riess, A. K. S. Camara, L. G. Kevin, J. An, and D. F. Stowe, “Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17 °C ischemia in intact hearts,” Cardiovascular Research, vol. 61, no. 3, pp. 580–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. M. L. Riess, A. K. S. Camara, E. Novalija, Q. Chen, S. S. Rhodes, and D. F. Stowe, “Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in Guinea pig intact hearts: reversal by 5-hydroxydecanoic acid,” Anesthesia and Analgesia, vol. 95, no. 6, pp. 1540–1546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Ferrari, P. Pedersini, M. Bongrazio et al., “Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion,” Basic Research in Cardiology, vol. 88, no. 5, pp. 495–512, 1993. View at Publisher · View at Google Scholar · View at Scopus
  79. D. De Stefani, A. Raffaello, E. Teardo, I. Szabó, and R. Rizzuto, “A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter,” Nature, vol. 476, no. 7360, pp. 336–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. D. De Stefani, M. Patron, and R. Rizzuto, “Structure and function of the mitochondrial calcium uniporter complex,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1853, no. 9, pp. 2006–2011, 2015. View at Publisher · View at Google Scholar
  81. T. M. Ye, S. Z. Zhang, and Q. Xia, “Role of mitochondrial calcium uniporter in myocardial hypoxia/reoxygenation induced injury,” Chinese Journal of Applied Physiology, vol. 22, pp. 136–140, 2006. View at Google Scholar
  82. M. Ahuja and S. Muallem, “The gatekeepers of mitochondrial calcium influx: MICU1 and MICU2,” EMBO Reports, vol. 15, no. 3, pp. 205–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. K. J. Kamer and V. K. Mootha, “MICU1 and MICU2 play nonredundant roles in the regulation of the mitochondrial calcium uniporter,” EMBO Reports, vol. 15, no. 3, pp. 299–307, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Mallilankaraman, P. Doonan, C. Cárdenas et al., “MICU1 is an essential gatekeeper for mcu-mediated mitochondrial Ca2+ uptake that regulates cell survival,” Cell, vol. 151, no. 3, pp. 630–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Patron, V. Checchetto, A. Raffaello et al., “MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity,” Molecular Cell, vol. 53, no. 5, pp. 726–737, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. W. Wang, Q. Xie, X. Zhou et al., “Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells,” Cancer Letters, vol. 358, no. 1, pp. 47–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Michela, V. Velia, P. Aldo, and P. Ada, “Role of connexin 43 in cardiovascular diseases,” European Journal of Pharmacology, vol. 768, pp. 71–76, 2015. View at Publisher · View at Google Scholar
  88. A. Rodriguez-Sinovas, K. Boengler, A. Cabestrero et al., “Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection,” Circulation Research, vol. 99, no. 1, pp. 93–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. K.-G. Shyu, B.-W. Wang, W.-P. Cheng, and H.-M. Lo, “MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction,” Canadian Journal of Cardiology, vol. 31, no. 5, pp. 679–690, 2015. View at Publisher · View at Google Scholar
  90. R. Schulz, P. M. Görge, A. Görbe, P. Ferdinandy, P. D. Lampe, and L. Leybaert, “Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection,” Pharmacology & Therapeutics, vol. 153, pp. 90–106, 2015. View at Publisher · View at Google Scholar
  91. N. Wang, E. De Vuyst, R. Ponsaerts et al., “Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 108, article 309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. G. Chen, J. Zhao, C. Liu, Y. Zhang, Y. Huo, and L. Zhou, “MG132 proteasome inhibitor upregulates the expression of connexin 43 in rats with adriamycin-induced heart failure,” Molecular Medicine Reports, vol. 12, no. 5, pp. 7595–7602, 2015. View at Publisher · View at Google Scholar
  93. G. Heusch, J. Musiolik, N. Gedik, and A. Skyschally, “Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion,” Circulation Research, vol. 109, no. 11, pp. 1302–1308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Szczepanek, E. J. Lesnefsky, and A. C. Larner, “Multi-tasking: nuclear transcription factors with novel roles in the mitochondria,” Trends in Cell Biology, vol. 22, no. 8, pp. 429–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. F. A. Zouein, R. Altara, Q. Chen, E. J. Lesnefsky, M. Kurdi, and G. W. Booz, “Pivotal importance of STAT3 in protecting the heart from acute and chronic stress: new advancement and unresolved issues,” Frontiers in Cardiovascular Medicine, vol. 2, article 36, 2015. View at Publisher · View at Google Scholar
  96. K. Szczepanek, Q. Chen, A. C. Larner, and E. J. Lesnefsky, “Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3,” Mitochondrion, vol. 12, no. 2, pp. 180–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Wegrzyn, R. Potla, Y.-J. Chwae et al., “Function of mitochondrial Stat3 in cellular respiration,” Science, vol. 323, no. 5915, pp. 793–797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. K. Szczepanek, Q. Chen, M. Derecka et al., “Mitochondrial-targeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species,” The Journal of Biological Chemistry, vol. 286, no. 34, pp. 29610–29620, 2011. View at Publisher · View at Google Scholar · View at Scopus